Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy

Monica Verdoia; Patrizia Pergolini; Roberta ROLLA; Claudia Ceccon; Marina CAPUTO; Gianluca AIMARETTI; Harry Suryapranata; Giuseppe De Luca

doi:10.1055/a-0787-1382

Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy

Monica Verdoia
, Patrizia Pergolini
, Roberta ROLLA
, Claudia Ceccon
, Marina CAPUTO
, Gianluca AIMARETTI
, Harry Suryapranata
, Giuseppe De Luca

Research output: Contribution to journal › Article › peer-review

Abstract

Enhanced platelet reactivity represents one of the major determinants of cardiovascular risk among diabetic patients. The aim of the present study was to evaluate the impact of metformin use on platelet reactivity in diabetic patients receiving dual antiplatelet therapy (DAPT).

Original language	English
Pages (from-to)	43-49
Number of pages	7
Journal	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Volume	129
Issue number	1
DOIs	https://doi.org/10.1055/a-0787-1382
Publication status	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1055/a-0787-1382

Cite this

@article{486a4393d42d48959009b3bb0fb0fdc6,

title = "Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy",

abstract = "Enhanced platelet reactivity represents one of the major determinants of cardiovascular risk among diabetic patients. The aim of the present study was to evaluate the impact of metformin use on platelet reactivity in diabetic patients receiving dual antiplatelet therapy (DAPT).",

author = "Monica Verdoia and Patrizia Pergolini and Roberta ROLLA and Claudia Ceccon and Marina CAPUTO and Gianluca AIMARETTI and Harry Suryapranata and \{De Luca\}, Giuseppe",

year = "2021",

month = jan,

day = "1",

doi = "10.1055/a-0787-1382",

language = "English",

volume = "129",

pages = "43--49",

journal = "EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY \& DIABETES",

issn = "0947-7349",

number = "1",

}

TY - JOUR

T1 - Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy

AU - Verdoia, Monica

AU - Pergolini, Patrizia

AU - ROLLA, Roberta

AU - Ceccon, Claudia

AU - CAPUTO, Marina

AU - AIMARETTI, Gianluca

AU - Suryapranata, Harry

AU - De Luca, Giuseppe

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Enhanced platelet reactivity represents one of the major determinants of cardiovascular risk among diabetic patients. The aim of the present study was to evaluate the impact of metformin use on platelet reactivity in diabetic patients receiving dual antiplatelet therapy (DAPT).

AB - Enhanced platelet reactivity represents one of the major determinants of cardiovascular risk among diabetic patients. The aim of the present study was to evaluate the impact of metformin use on platelet reactivity in diabetic patients receiving dual antiplatelet therapy (DAPT).

UR - https://iris.uniupo.it/handle/11579/100405

U2 - 10.1055/a-0787-1382

DO - 10.1055/a-0787-1382

M3 - Article

SN - 0947-7349

VL - 129

SP - 43

EP - 49

JO - EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

JF - EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

IS - 1

ER -

Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this